Sasha Zivkovic

Sasha Zivkovic, MD, PhD, is a tenured Professor of Neurology at Yale School of Medicine, serving as Academic Chief of Neuromuscular Medicine and Clinical Director of the Yale CMTA Center of Excellence for adult Charcot-Marie-Tooth disease. With dual medical and doctoral degrees from the University of Zagreb, their career spans clinical leadership in neuromuscular disorders and international collaborative research.

• PhD in Biomedicine (University of Zagreb, 2009)
• MD (University of Zagreb, 1992)

Dr. Zivkovic's research focuses on neuromuscular disease, particularly hereditary neuropathies, amyloid neuropathies, and autoimmune neurological conditions like Guillain-Barré Syndrome. Their recent publications emphasize genotype-phenotype correlations, protein misfolding pathologies, and international standards for neurological outcomes.

Key publication trends include:

• Advancing understanding of Transthyretin Amyloidosis through multicenter THAOS registry analyses
• Developing standardized outcome measures for Guillain-Barré Syndrome across 15 countries
• Investigating sex-based differences in amyloidosis manifestations
• Exploring post-infectious neurological complications including SARS-CoV-2

Scientific contributions:

• International Validation of Erasmus GBS Outcome Scores
• Editorial Board Member, Journal of Clinical Neuromuscular Disease
• Principal investigator in multiple neuromuscular disease clinical studies
• Recipient of American Academy of Neurology Fellowship

Clinically, Dr. Zivkovic directs the Yale CMTA Center of Excellence and participates in multidisciplinary programs for cardiac amyloidosis and neurogenetics. They maintain active roles in medical education through lectures on neuroimmunology and infection-immunization in NMD.